The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Leptomeningeal metastases: a RANO proposal for response criteria
Open accessAbstract
Leptomeningeal metastases (LM) currently lack standardization with respect to response assessment. A Response Assessment in Neuro-Oncology (RANO) working group with expertise in LM developed a consensus proposal for evaluating patients treated for this disease. Three basic elements in assessing response in LM are proposed: a standardized neurological examination, cerebral spinal fluid (CSF) cytology or flow cytometry, and radiographic evaluation. The group recommends that all patients enrolling in clinical trials undergo CSF analysis (cytology in all cancers; flow cytometry in hematologic cancers), complete contrast-enhanced neuraxis MRI, and in instances of planned intra-CSF therapy, radioisotope CSF flow studies. In conjunction with the RANO Neurological Assessment working group, a standardized instrument was created for assessing the neurological exam in patients with LM. Considering that most lesions in LM are nonmeasurable and that assessment of neuroimaging in LM is subjective, neuroimaging is graded as stable, progressive, or improved using a novel radiological LM response scorecard. Radiographic disease progression in isolation (ie, negative CSF cytology/flow cytometry and stable neurological assessment) would be defined as LM disease progression. The RANO LM working group has proposed a method of response evaluation for patients with LM that will require further testing, validation, and likely refinement with use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shapiro, W. R., Young, D. F., & Mehta, B. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507242930402 · Cited by 681
Glantz, M., Jaeckle, K. A., Chamberlain, M. C., Phuphanich, S., Recht, L. D., Swinnen, L. J., Maria, B., LaFollette, S., Schumann, G. B., Cole, B. F., et al. (1999) · PubMed · Cited by 529
Self-citationPatterns of Contrast Enhancement in the Brain and Meninges
Smirniotopoulos, J. G., Murphy, F. M., Rushing, E. J., Rees, J. H., & Schroeder, J. W. (2007) · RadioGraphics · doi:10.1148/rg.272065155 · Cited by 502
Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology
Glass, J. P., Melamed, M., Chernik, N. L., & Posner, J. B. (1979) · Neurology · doi:10.1212/wnl.29.10.1369 · Cited by 493
Cerebrospinal fluid cytology in patients with cancer: Minimizing false-negative results
Glantz, M. J., Cole, B. F., Glantz, L. K., Cobb, J., Mills, P., Lekos, A., Walters, B. C., & Recht, L. D. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980215)82:4<733::aid-cncr17>3.0.co;2-z · Cited by 456
Leptomeningeal metastases in the MRI era
Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a69 · Cited by 432
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
Freilich, R. J., Krol, G., & Deangelis, L. M. (1995) · Annals of Neurology · doi:10.1002/ana.410380111 · Cited by 412
Glantz, M. J., LaFollette, S., Jaeckle, K. A., Shapiro, W., Swinnen, L., Rozental, J. R., Phuphanich, S., Rogers, L. R., Gutheil, J. C., Batchelor, T., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3110 · Cited by 402
Self-citationGrossman, S. A., Finkelstein, D. M., Ruckdeschel, J. C., Trump, D. L., Moynihan, T., & Ettinger, D. S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.561 · Cited by 364
Hitchins, R. N., Bell, D. R., Woods, R. L., & Levi, J. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1655 · Cited by 352
Boogerd, W., van den Bent, M. J., Koehler, P. J., Heimans, J. J., van der Sande, J. J., Aaronson, N. K., Hart, A. A. M., Benraadt, J., & Vecht, C. J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.012 · Cited by 286
Self-citationQuijano, S., López, A., Manuel Sancho, J., Panizo, C., Debén, G., Castilla, C., Antonio García-Vela, J., Salar, A., Alonso-Vence, N., González-Barca, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7089 · Cited by 215
Brain: Gadolinium-enhanced Fast Fluid-attenuated Inversion-Recovery MR Imaging
Mathews, V. P., Caldemeyer, K. S., Lowe, M. J., Greenspan, S. L., Weber, D. M., & Ulmer, J. L. (1999) · Radiology · doi:10.1148/radiology.211.1.r99mr25257 · Cited by 210
Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A. G., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B. B., Maringwa, J., et al. (2014) · Cancer · doi:10.1002/cncr.28382 · Cited by 206
Chamberlain, M., Soffietti, R., Raizer, J., Ruda, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou089 · Cited by 163
Self-citationCerebrospinal fluid flow abnormalities in patients with neoplastic meningitis
Grossman, S. A., Trump, D. L., Chen, D. C. P., et al. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90404-1 · Cited by 161
Armstrong, T. S., Wefel, J. S., Wang, M., Gilbert, M. R., Won, M., Bottomley, A., Mendoza, T. R., Coens, C., Werner‐Wasik, M., Brachman, D. G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6067 · Cited by 153
Fukuoka, H., Hirai, T., Okuda, T., Shigematsu, Y., Sasao, A., Kimura, E., Hirano, T., Yano, S., Murakami, R., & Yamashita, Y. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1937 · Cited by 152
MR imaging of leptomeningeal metastases: comparison of three sequences.
Singh, S. K., Leeds, N. E., & Ginsberg, L. E. (2002) · PubMed · Cited by 152
Lin, N., Wefel, J. S., Lee, E. Q., Schiff, D., van den Bent, M. J., Soffietti, R., Suh, J. H., Vogelbaum, M. A., Mehta, M. P., Dancey, J. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70308-5 · Cited by 147
Self-citationPrognostic significance of sup 111 Indium-DTPA CSF flow studies in leptomeningeal metastases
Chamberlain, M. C., & Kormanik, P. A. (1996) · Neurology · doi:10.1212/wnl.46.6.1674 · Cited by 146
Self-citationFlow cytometric characterization of cerebrospinal fluid cells
de Graaf, M. T., de Jongste, A. H. C., Kraan, J., et al. (2011) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20603 · Cited by 139
Radioisotope CSF flow studies in leptomeningeal metastases
Chamberlain, M. C. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005982826121 · Cited by 128
Self-citationA multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Groves, M. D., Glantz, M., Chamberlain, M. C., Baumgartner, K., Conrad, C. A., Hsu, S. H., Wefel, J. S., Gilbert, M. R., Ictech, S. E., Hunter, K., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-059 · Cited by 128
Self-citationRare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
Nayak, L., Fleisher, M., Gonzalez-Espinoza, R., Lin, O., Panageas, K. S., Reiner, A. S., Liu, C.-M., DeAngelis, L. M., & Omuro, A. M. P. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f183f · Cited by 120
Mason, W. P., Yeh, S. D. J., & DeAngelis, L. M. (1998) · Neurology · doi:10.1212/wnl.50.2.438 · Cited by 115
Detection of cancer cells in the cerebrospinal fluid: current methods and future directions
Weston, C. L., Glantz, M., & Connor, J. R. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-14 · Cited by 110
Patel, A. S., Allen, J. E., Dicker, D. T., Peters, K. L., Sheehan, J. M., Glantz, M., & El‐Deiry, W. S. (2011) · Oncotarget · doi:10.18632/oncotarget.336 · Cited by 96
Mamourian, A. C., Hoopes, P. J., & Lewis, L. D. (2000) · PubMed · Cited by 95
Siegal, T. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005999228846 · Cited by 86
Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis
Rogers, L. R., Duchesneau, P. M., Nuñez, C., et al. (1992) · Neurology · doi:10.1212/wnl.42.6.1239 · Cited by 83
Cytologically negative carcinomatous meningitis: Usefulness of CSF biochemical markers
Chamberlain, M. C. (1998) · Neurology · doi:10.1212/wnl.50.4.1173 · Cited by 83
Self-citationGroves, M. D., Hess, K. R., Puduvalli, V. K., Colman, H., Conrad, C. A., Gilbert, M. R., Weinberg, J. S., Cristofanilli, M., Yung, W. K. A., & Liu, T. J. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9819-2 · Cited by 80
Self-citationFrequency of unexplained meningeal enhancement in the brain after lumbar puncture.
Mittl, R. L., & Yousem, D. M. (1994) · PubMed · Cited by 75
A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid
Dux, R., Kindler‐Röhrborn, A., Annas, M., et al. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90159-7 · Cited by 73
Rhun, É. L., Massin, F., Tu, Q., Bonneterre, J. M., Bittencourt, M. D. C., & Faure, G. C. (2012) · BMC Clinical Pathology · doi:10.1186/1472-6890-12-21 · Cited by 69
Shapiro, W. R., Schmid, M., Glantz, M., & Miller, J. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.1528 · Cited by 68
Rhun, É. L., Tu, Q., Bittencourt, M. D. C., Farré, I., Mortier, L., Cai, H., Kohler, C., & Faure, G. C. (2013) · Medical Oncology · doi:10.1007/s12032-013-0538-3 · Cited by 65
Subirá, D., Simó, M., Illán, J., Serrano, C., Castañón, S., Gonzalo, R., Granizo, J. J., Martinez‐García, M., Navarro, M., Pardo, J., et al. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9716-3 · Cited by 64
Known and Emerging Biomarkers of Leptomeningeal Metastasis and its Response to Treatment
Walbert, T., & Groves, M. D. (2010) · Future Oncology · doi:10.2217/fon.09.167 · Cited by 17
Self-citation
Cited by
Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx221 · Cited by 637
Self-citationResponse Assessment in Neuro-Oncology Clinical Trials
Wen, P. Y., Chang, S. M., Van den Bent, M. J., Vogelbaum, M. A., Macdonald, D. R., & Lee, E. Q. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.7511 · Cited by 435
Self-citationYang, J. C. H., Kim, S.-W., Kim, D.-W., Lee, J.-S., Cho, B. C., Ahn, J.-S., Lee, D. H., Kim, T. M., Goldman, J. W., Natale, R. B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00457 · Cited by 395
Epidemiology of brain metastases and leptomeningeal disease
Lamba, N., Wen, P. Y., & Aizer, A. A. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab101 · Cited by 406
Self-citationThe Evolving Landscape of Brain Metastasis
Valiente, M., Ahluwalia, M. S., Boire, A., Brastianos, P. K., Goldberg, S. B., Lee, E. Q., Le Rhun, E., Preusser, M., Winkler, F., & Soffietti, R. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.01.003 · Cited by 309
Self-citation
Metadata
- Authors
- Chamberlain, M., Junck, L., Brandsma, D., Soffietti, R., Rudà, R., Raizer, J., Boogerd, W., Taillibert, S., Groves, M. D., Rhun, E. L., Walker, J., van den Bent, M., Wen, P. Y., & Jaeckle, K. A.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-29
- Volume
- 19
- Issue
- 4
- Pages
- now183
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2168394700
- Cited by
- 317
- References
- 40
- FWCI
- 21.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.